[Ataxia-telangiectasia with acute lymphoblastic leukemia].
D000361:Agammaglobulinemia; D000747:Anemia, Hypochromic / Q000150:complications; D000974:Antibodies, Antinuclear / Q000032:analysis; D001260:Ataxia Telangiectasia / Q000150:complications*; D001264:Athetosis / Q000150:complications; D001323:Autoantibodies; D002531:Cerebellum / Q000503:physiopathology; D002648:Child; D002819:Chorea / Q000150:complications; D003348:Cortisone / Q000627:therapeutic use; D005116:Extrapyramidal Tracts / Q000503:physiopathology; D005128:Eye Diseases / Q000150:complications; D005133:Eye Movements; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000150:complications; D007122:Immunoelectrophoresis; D007074:Immunoglobulin G; D066298:In Vitro Techniques; D007945:Leukemia, Lymphoid / Q000150:complications*; D008214:Lymphocytes; D008221:Lymphoid Tissue / Q000503:physiopathology; D008228:Lymphoma, Non-Hodgkin / Q000150:complications; D008297:Male; D009069:Movement Disorders / Q000150:complications; D012871:Skin Diseases / Q000150:complications; D013064:Speech Disorders / Q000150:complications; D013684:Telangiectasis / Q000150:complications; D014750:Vincristine / Q000627:therapeutic use
D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D007074:Immunoglobulin G; D014750:Vincristine; D003348:Cortisone
Association d'une ataxie-télangiectasie avec une leucémie aiguë lymphoblastique.